Skip to main content
. 2022 Aug 5;10(8):1899. doi: 10.3390/biomedicines10081899

Figure 4.

Figure 4

Reduced hepatic insulin clearance causes hepatic insulin resistance independently of NEFA release. Liver-specific Ceacam1 null mutation causes reduction in insulin clearance which, in turn, leads to chronic hyperinsulinemia. This drives hepatic insulin resistance and lipogenesis, followed by redistribution of VLDL-TG to WAT and lipolysis.